RB1 gene deletion detection probe uses an orange-red fluorescent label RB1 gene, and the RB1 probe bind to the target detection site by in situ hybridization. This method is used to detect the abnormalities in multiple myeloma genes, and provide clinical reference for the differentiation, prognosis and medication for leukemia patients.